A detailed history of Vanguard Group Inc transactions in Embecta Corp. stock. As of the latest transaction made, Vanguard Group Inc holds 6,997,452 shares of EMBC stock, worth $142 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,997,452
Previous 7,288,359 3.99%
Holding current value
$142 Million
Previous $91.1 Million 8.3%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.46 - $16.56 $3.33 Million - $4.82 Million
-290,907 Reduced 3.99%
6,997,452 $98.7 Million
Q2 2024

Aug 13, 2024

BUY
$10.13 - $14.6 $753,337 - $1.09 Million
74,367 Added 1.03%
7,288,359 $91.1 Million
Q1 2024

May 10, 2024

BUY
$12.35 - $19.33 $2.32 Million - $3.63 Million
187,916 Added 2.67%
7,213,992 $95.7 Million
Q4 2023

Feb 14, 2024

BUY
$12.87 - $19.09 $263,950 - $391,516
20,509 Added 0.29%
7,026,076 $133 Million
Q3 2023

Nov 14, 2023

BUY
$15.0 - $22.17 $249,525 - $368,797
16,635 Added 0.24%
7,005,567 $105 Million
Q2 2023

Aug 14, 2023

SELL
$21.6 - $30.69 $2.22 Million - $3.15 Million
-102,731 Reduced 1.45%
6,988,932 $151 Million
Q1 2023

Jul 14, 2023

BUY
$23.07 - $32.77 $1,637 - $2,326
71 Added 0.0%
7,091,663 $199 Million
Q1 2023

May 15, 2023

BUY
$23.07 - $32.77 $521,243 - $740,405
22,594 Added 0.32%
7,091,592 $199 Million
Q4 2022

Feb 10, 2023

BUY
$25.29 - $35.48 $4.92 Million - $6.91 Million
194,679 Added 2.83%
7,068,998 $179 Million
Q3 2022

Nov 14, 2022

BUY
$24.0 - $33.42 $2.44 Million - $3.4 Million
101,866 Added 1.5%
6,874,319 $198 Million
Q2 2022

Aug 12, 2022

BUY
$24.78 - $33.36 $168 Million - $226 Million
6,772,453 New
6,772,453 $171 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.